| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-07 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.29 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-05 |